Myosin BINDING SPECIFICITY DUX4 Regenerative medicine PABPN1 MUTATIONS Muscle strength Functional genomics RNA Satellite cell Epigenetics Myositis Haploinsufficiency Annexin A2 Antisens oligonucleotides Exon-skipping Geriatric assessment Differentiation Antiserum Nuclear envelope DNA methylation Myotube Xenograft GENE Mass spectrometry Muscle fibrosis Effector T cells Pharyngeal muscle Myoblast Neuromuscular disease Aav-U7 OPMD Actin Oculopharyngeal muscular dystrophy Pax7 Anti-fibrotic pharmacotherapies Dysferlinopathy Muscle dystrophy APOPTOSIS AUTOPHAGY Duchenne muscular dystrophy Muscle Regulatory T cells Amyotrophic Lateral Sclerosis Calcium Aggregate Aged Muscular dystrophy 2-D PAGE Bile salt hydrolases Satellite cells Dystrophin Muscle stem cells Omics Akt Cell therapy Myogenesis AAV PABPN1 agregates Regeneration FAPs ARN Intercellular communication Arbovirus Inflammation DMD Gene replacement Dysferlin Metabolism AChR antibodies Transcriptomics Human Myoblasts Neuromuscular junction NMJ Andermann syndrome Fibrosis Sarcopenia FSHD Adipose tissue Triplet expansion disease Autoimmune diseases Autologous Alphavirus AAV vectors Agrégats de PABPN1 Dystrophie musculaire oculopharyngée ALS Ageing Thérapie génique Anti-acetylcholine receptor antibodies Atrophy Myopathy Skeletal muscle Gene therapy Alzheimer's disease Accelerometry Cross-bridge kinetics Lamins Biomarker Myopathies